Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells

Jam

Member
Joined
Aug 10, 2018
Messages
2,212
Age
52
Location
Piedmont

Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes coronavirus disease (COVID-19) is one of the most serious global health crises in recent history. COVID-19 patient symptoms range from life-threatening to mild and asymptomatic, which presents unique problems in identifying, quarantining, and treating the affected individuals. The emergence of unusual symptoms among survivors, now referred to as “Long COVID”, is concerning, especially since much about the condition and the treatment of it is still relatively unknown. Evidence so far also suggests that some of these symptoms can be attributed to vascular inflammation. Although famotidine, the commonly used histamine H2 receptor (H2R) blocker, was shown to have no antiviral activity, recent reports indicate that it could prevent adverse outcomes in COVID-19 patients. Histamine is a classic proinflammatory mediator, the levels of which increase along with other cytokines during COVID-19 infection. Histamine activates H2R signaling, while famotidine specifically blocks H2R activation. Investigating the effects of recombinant SARS-CoV-2 spike protein S1 Receptor-Binding Domain (Spike) on ACE2 expression in cultured human coronary artery endothelial cells, we found that the presence of histamine potentiated spike-mediated ACE2 internalization into endothelial cells. This effect was blocked by famotidine, protein kinase A inhibition, or by H2 receptor protein knockdown. Together, these results indicate that histamine and histamine receptor signaling is likely essential for spike protein to induce ACE2 internalization in endothelial cells and cause endothelial dysfunction and that this effect can be blocked by the H2R blocker, famotidine.

 

JudiBlueHen

Member
Forum Supporter
Joined
Jun 26, 2017
Messages
482
Shortly after a rather severe bout of Covid (un-jabbed), my pulmonologist put me on 40mg famotidine at bedtime for chronic cough. It not only reduced my cough but seems to have helped my recovery. I plan to take it indefinitely as I have no ill effects.
 

tankasnowgod

Member
Joined
Jan 25, 2014
Messages
8,131
This experiment got me thinking...... how did they manage to isolate and purify the "Spike Protein" from SARS-Cov-2, when they never even managed to isolate and purify this "Novel Corona Virus" from the other cellular material when they allegedly "discovered" it in the first place?


The short answer is..... they didn't. The study itself doesn't even make such a claim (contrary to how the title is written). The whole story is told in right here, in the Abstract-

Investigating the effects of recombinant SARS-CoV-2 spike protein S1 Receptor-Binding Domain (Spike) on ACE2 expression in cultured human coronary artery endothelial cells, we found that the presence of histamine potentiated spike-mediated ACE2 internalization into endothelial cells.

Did you gloss over that word "recombinant?" You shouldn't. It means this is a synthetic protein.


Recombinant proteins are formed by transfecting foreign genes into a host cell. Recombinant proteins are commonly used to produce pharmaceutical products, protein-based polymers for drug delivery, antibodies and enzymes for disease treatment, protein scaffolds for tissue engineering, as well as for a myriad of other uses.


Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination (such as molecular cloning) that bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.


1: relating to or exhibiting genetic recombinationrecombinant progeny
2a: relating to or containing genetically engineered DNA
b: produced by genetic engineering

As always, the "Materials and Methods" section gives further detail-

Cell culture​

The human primary coronary artery endothelial cells were purchased from Cell Biologics Inc. The cells were cultured in the endothelial cell medium containing (0.5 ml VEGF, Heparin, EGF, FGF, Hydrocortisone, L-Glutamine, and Antibiotic–Antimycotic Solution) supplemented with 2% fetal bovine serum.

Reagents​

The SARS-CoV-2 (COVID-19) S1 Recombinant Protein (cat. no. 97-092) was purchased from ProSci Inc. (Poway, CA) and used at a final concentration of 10 μg/ml. The endothelial cells were treated with spike protein at the final concentration for the required time before surface biotinylation experiments were carried out. The ACE2 antibody was purchased from Abnova (Taipei, Taiwan, cat. no. PAB13443). Histamine, famotidine, and PKI were purchased from Sigma-Aldrich (St. Louis, MO, United States). siRNA to H2 receptor and scrambled siRNA were purchased from Thermo Fisher Scientific Inc.

Here is the listing from ProSci-


They can claim this synthetic protein is the same as the "Spike Protein" from "SARS-Cov-2, but since neither the alleged virus, nor the alleged spike protein has been isolated and purified, how would anyone possibly know?

Although, since ProSci charges over $500 for 0.1 mg (!!!!), I'm guessing they don't care. And probably prefer no one ask that question.
 

appotis

Member
Joined
Jan 10, 2018
Messages
35

Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm

Background
Severe COVID-19 is characterized by pro-inflammatory cytokine release syndrome (cytokine storm) which causes high morbidity and mortality. Recent observational and clinical studies suggest famotidine, a histamine 2 receptor (H2R) antagonist widely used to treat gastroesophageal reflux disease, attenuates the clinical course of COVID-19. Because evidence is lacking for a direct antiviral activity of famotidine, a proposed mechanism of action is blocking the effects of histamine released by mast cells. Here we hypothesized that famotidine activates the inflammatory reflex, a brain-integrated vagus nerve mechanism which inhibits inflammation via alpha 7 nicotinic acetylcholine receptor (α7nAChR) signal transduction, to prevent cytokine storm.

Methods
The potential anti-inflammatory effects of famotidine and other H2R antagonists were assessed in mice exposed to lipopolysaccharide (LPS)-induced cytokine storm. As the inflammatory reflex is integrated and can be stimulated in the brain, and H2R antagonists penetrate the blood brain barrier poorly, famotidine was administered by intracerebroventricular (ICV) or intraperitoneal (IP) routes.

Results
Famotidine administered IP significantly reduced serum and splenic LPS-stimulated tumor necrosis factor (TNF) and IL-6 concentrations, significantly improving survival. The effects of ICV famotidine were significantly more potent as compared to the peripheral route. Mice lacking mast cells by genetic deletion also responded to famotidine, indicating the anti-inflammatory effects are not mast cell-dependent. Either bilateral sub-diaphragmatic vagotomy or genetic knock-out of α7nAChR abolished the anti-inflammatory effects of famotidine, indicating the inflammatory reflex as famotidine’s mechanism of action. While the structurally similar H2R antagonist tiotidine displayed equivalent anti-inflammatory activity, the H2R antagonists cimetidine or ranitidine were ineffective even at very high dosages.

Conclusions
These observations reveal a previously unidentified vagus nerve-dependent anti-inflammatory effect of famotidine in the setting of cytokine storm which is not replicated by high dosages of other H2R antagonists in clinical use. Because famotidine is more potent when administered intrathecally, these findings are also consistent with a primarily central nervous system mechanism of action.
 
EMF Mitigation - Flush Niacin - Big 5 Minerals

Similar threads

Back
Top Bottom